Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

ESSA Pharma Inc. Director's Dealing 2024

Mar 28, 2024

35249_dirs_2024-03-28_01a93a85-7811-42e2-bad8-ee59db7f4ab6.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ESSA Pharma Inc. (EPIX)
CIK: 0001633932
Period of Report: 2024-03-25

Reporting Person: Glickman Richard M (N/A)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2024-03-25 Options $9.04 A 70000 Acquired 2034-03-25 Common Shares (70000) Direct

More from ESSA Pharma Inc.

Regulatory Filings 2025
Nov 17
Major Shareholding Notification 2025
Nov 14
Major Shareholding Notification 2025
Nov 14
Regulatory Filings 2025
Oct 28
Director's Dealing 2025
Oct 15
Director's Dealing 2025
Oct 15
Director's Dealing 2025
Oct 15
Director's Dealing 2025
Oct 15
Director's Dealing 2025
Oct 15
Director's Dealing 2025
Oct 15
View all filings →